InspireMD director awarded 44,030 restricted shares

InspireMD, Inc. director Danny L. Dearen reported a stock award of 44,030 shares of common stock on January 14, 2026.

Rhea-AI Filing Summary

InspireMD, Inc. director Danny L. Dearen reported a stock award of 44,030 shares of common stock on January 14, 2026. The Form 4 shows the shares were acquired at a price of $0 per share as a grant of restricted stock.

According to the footnote, these 44,030 shares are restricted stock that will vest on January 14, 2027, the one-year grant anniversary date, subject to his continued service. Following this grant, Dearen beneficially owns 102,047 shares of InspireMD common stock in direct ownership.

Insider Trade Summary

Grant/Award: 44,030 shares

Grant/Award 1 txn

Insider Dearen Danny L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	44,030	$0.00	$0.00

Holdings After Transaction: Common Stock — 102,047 shares (Direct)

Footnotes (1)

1. F1. These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did InspireMD (NSPR) report in this Form 4?

The Form 4 reports that director Danny L. Dearen acquired 44,030 shares of InspireMD common stock on January 14, 2026 as a stock grant at $0 per share.

What type of shares did InspireMD director Danny Dearen receive?

Danny Dearen received restricted stock in the form of 44,030 shares of InspireMD common stock, as disclosed in the Form 4 footnote.

When do Danny Dearens restricted InspireMD (NSPR) shares vest?

The 44,030 restricted shares are scheduled to vest on January 14, 2027, described as the "One Year Grant Anniversary Date," subject to his continued service.

How many InspireMD shares does Danny Dearen own after this transaction?

After the reported grant, Danny Dearen beneficially owns 102,047 shares of InspireMD common stock, held in direct ownership.

What role does Danny L. Dearen have at InspireMD (NSPR)?

According to the filing, Danny L. Dearen is a director of InspireMD, Inc. He is not listed as an officer or a 10% owner in this report.

Is this InspireMD (NSPR) Form 4 filed for one or multiple reporting persons?

The Form 4 is indicated as being filed by one reporting person, specifically director Danny L. Dearen.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/16/2026 - 06:09 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dearen Danny L.

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FL 33126

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/14/2026		A		44,030(1)	A	$0	102,047	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Remarks:

Exhibit 24.1: Power of Attorney

	/s/ Michael Lawless, Attorney-in-Fact for Danny L. Dearen	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.